THEMIS MEDICARE
Back to Cashflow Statement
|
THEMIS MEDICARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.77 Cr | ₹0.14 Cr | ₹-18 Cr | ₹-26 Cr | ₹6.72 Cr |
What is the latest Cash Flow from Financing Activities ratio of THEMIS MEDICARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.77 Cr |
Mar2023 | ₹0.14 Cr |
Mar2022 | ₹-18 Cr |
Mar2021 | ₹-26 Cr |
Mar2020 | ₹6.72 Cr |
How is Cash Flow from Financing Activities of THEMIS MEDICARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.77 Cr | Negative | |
Mar2023 | ₹0.14 Cr | Positive | |
Mar2022 | ₹-18 Cr | Negative | |
Mar2021 | ₹-26 Cr | Negative | |
Mar2020 | ₹6.72 Cr | - |
Compare Cash Flow from Financing Activities of peers of THEMIS MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THEMIS MEDICARE | ₹2,663.4 Cr | 6.3% | 10.6% | 83.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
THEMIS MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THEMIS MEDICARE | 6.3% |
10.6% |
83.5% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses